ELOXATIN - 0024-0591-20 - (oxaliplatin)

Alphabetical Index


Drug Information of ELOXATIN

Product NDC: 0024-0591
Proprietary Name: ELOXATIN
Non Proprietary Name: oxaliplatin
Active Ingredient(s): 100    mg/1 & nbsp;   oxaliplatin
Administration Route(s): INTRAVENOUS
Dosage Form(s): INJECTION, SOLUTION, CONCENTRATE
Coding System: National Drug Codes(NDC)

Labeler Information of ELOXATIN

Product NDC: 0024-0591
Labeler Name: sanofi-aventis U.S. LLC
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA021759
Marketing Category: NDA
Start Marketing Date: 20060602

Package Information of ELOXATIN

Package NDC: 0024-0591-20
Package Description: 1 INJECTION, SOLUTION, CONCENTRATE in 1 CARTON (0024-0591-20)

NDC Information of ELOXATIN

NDC Code 0024-0591-20
Proprietary Name ELOXATIN
Package Description 1 INJECTION, SOLUTION, CONCENTRATE in 1 CARTON (0024-0591-20)
Product NDC 0024-0591
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name oxaliplatin
Dosage Form Name INJECTION, SOLUTION, CONCENTRATE
Route Name INTRAVENOUS
Start Marketing Date 20060602
Marketing Category Name NDA
Labeler Name sanofi-aventis U.S. LLC
Substance Name OXALIPLATIN
Strength Number 100
Strength Unit mg/1
Pharmaceutical Classes Platinum-based Drug [EPC],Platinum-containing Compounds [Chemical/Ingredient]

Complete Information of ELOXATIN


General Information